E
Salarius Pharmaceuticals, Inc. SLRX
$0.86 -$0.01-1.71% NASDAQ
Recommendation
Prev Close
$0.86
Volume
13,310
Avg Vol (90D)
1,388,658
Market Cap
$5.01M
Dividend & Yield
--
52-Week Range
$0.71 - $108.00
P/E (TTM)
--
EPS (TTM)
-$35.94
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Salarius Pharmaceuticals, Texas Biomed collaborate on Avian Flu study
12/1/2025 - The Fly
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
12/1/2025 - GuruFocus
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
12/1/2025 - Globe Newswire
Salarius Pharmaceuticals (NASDAQ:SLRX) CFO Mark Rosenblum Purchases 20,000 Shares
11/21/2025 - Ticker Report
Salarius Pharmaceuticals (NASDAQ:SLRX) CFO Purchases $16,000.00 in Stock
11/21/2025 - MarketBeat
Salarius Pharmaceuticals Announces New Executive Appointments
11/19/2025 - TipRanks Financial Blog
Salarius Pharmaceuticals (SLRX) Maintains Nasdaq Listing Despite Reporting Error
11/19/2025 - GuruFocus
Salarius Pharmaceuticals affirms shares continue to trade on the Nasdaq
11/19/2025 - TipRanks Financial Blog
Salarius Pharmaceuticals affirms shares continue to trade on the Nasdaq
11/19/2025 - The Fly
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol SLRX
11/19/2025 - Globe Newswire
Salarius Pharmaceuticals (NASDAQ:SLRX) Releases Quarterly Earnings Results
11/15/2025 - Ticker Report
Penny Stocks To Follow Now - November 12th
11/13/2025 - MarketBeat
Salarius Pharmaceuticals Completes $7M Offering and Merger
11/13/2025 - TipRanks Financial Blog
3 Penny Stocks to Watch Now, 11/13/25
11/13/2025 - TipRanks Financial Blog
Salarius Pharmaceuticals (SLRX) Completes Merger with Decoy Therapeutics
11/13/2025 - GuruFocus
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
11/13/2025 - GuruFocus
Salarius Pharmaceuticals, Decoy Therapeutics complete merger
11/13/2025 - TipRanks Financial Blog
Salarius Pharmaceuticals, Decoy Therapeutics complete merger
11/13/2025 - The Fly
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
11/13/2025 - Globe Newswire
Strong Earnings and Biotech Resilience Define the Midweek Momentum
11/12/2025 - Globe Newswire
Why Is Salarius Pharmaceuticals Stock (SLRX) Up 65% Today?
11/12/2025 - TipRanks Financial Blog
Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?
11/12/2025 - Benzinga
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
11/11/2025 - GuruFocus
Salarius Pharmaceuticals (SLRX) Announces $7M Public Offering
11/11/2025 - GuruFocus
Salarius Pharmaceuticals announces pricing of $7M offering of stock, warrants
11/11/2025 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$5.06M
EBIT (TTM)
-$5.07M
Net Income (TTM)
-$5.00M
Balance Sheet
Total Assets (Q)
$6.10M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$1.85M
Book Value Per Share (Q)
$4.50
Cash Flow
Cash from Operations (TTM)
-$4.43M
Cash from Investing (TTM)
-$200.00K
Cash from Financing (TTM)
$6.16M
Net Change in Cash (TTM)
$1.53M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
0.60
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
-28.72%
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Nov 19, 2025 - $0.71
52-week High
Jan 13, 2025 - $108.00
Valuation
Market Cap
$5.01M - Nano Cap
Enterprise Value
$204.83K
Price/Sales (TTM)
--
Price/Book (Q)
0.19
Dividends and Shares
Shares Outstanding
0.48
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.salariuspharma.com
Phone Number
713 913 5608
Address
2450 Holcombe Blvd.
Houston, TX 77021
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed